X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (735) 735
Paper (331) 331
Publication (280) 280
Book / eBook (29) 29
Report (15) 15
Book Chapter (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
experiment (336) 336
physics (321) 321
particle physics (316) 316
high energy physics - experiment (298) 298
physics - high energy physics - experiment (248) 248
humans (209) 209
index medicus (205) 205
high energy physics (188) 188
female (169) 169
physics of elementary particles and fields (165) 165
male (147) 147
particle physics - experiment (136) 136
nuclear experiment (123) 123
middle aged (111) 111
physics, particles & fields (103) 103
phenomenology (102) 102
elementary particles, quantum field theory (92) 92
quantum field theories, string theory (92) 92
adult (89) 89
physical sciences (88) 88
natural sciences (86) 86
naturvetenskap (86) 86
aged (83) 83
fysik (82) 82
hadron-hadron scattering (80) 80
classical and quantum gravitation, relativity theory (65) 65
quantum physics (65) 65
analysis (60) 60
research (58) 58
cern lhc coll (57) 57
nuclear physics (55) 55
risk factors (54) 54
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (51) 51
hep (50) 50
experimental results (48) 48
collisions (47) 47
物理学 (47) 47
mortality (46) 46
astronomy & astrophysics (44) 44
large hadron collider (43) 43
spain (43) 43
astrophysics (42) 42
care and treatment (42) 42
health aspects (41) 41
cms (38) 38
prospective studies (38) 38
surgery (36) 36
ex (34) 34
high energy astrophysical phenomena (34) 34
prognosis (33) 33
research article (33) 33
spain - epidemiology (33) 33
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (32) 32
risk (32) 32
infectious diseases (31) 31
instrumentation and detectors (31) 31
multidisciplinary sciences (30) 30
patients (30) 30
physics, nuclear (30) 30
subatomic physics (30) 30
subatomär fysik (30) 30
treatment outcome (30) 30
astronomy, astrophysics and cosmology (29) 29
diagnosis (29) 29
medicine (29) 29
mutation (29) 29
adolescent (28) 28
cancer (28) 28
epidemiology (28) 28
animals (27) 27
detectors (27) 27
measurement science and instrumentation (27) 27
nuclear energy (27) 27
nuclear physics, heavy ions, hadrons (27) 27
oncology (27) 27
young adult (27) 27
abridged index medicus (26) 26
aged, 80 and over (26) 26
hospitals (26) 26
disease (25) 25
management (25) 25
cohort studies (24) 24
medical research (24) 24
medicine, general & internal (24) 24
p p: scattering (24) 24
parton distributions (24) 24
física (23) 23
immunology (22) 22
medicine & public health (22) 22
nuclear and high energy physics (22) 22
population (22) 22
regular - experimental physics (22) 22
science (22) 22
decay (21) 21
microbiology (21) 21
genetic aspects (20) 20
physics and astronomy (20) 20
physics, multidisciplinary (20) 20
retrospective studies (20) 20
scattering [p p] (20) 20
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (15) 15
UTL at Downsview - May be requested (8) 8
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Victoria University E.J. Pratt - Stacks (3) 3
UofT at Mississauga - Stacks (2) 2
Gerstein Science - Stacks (1) 1
Music - Stacks (1) 1
OISE - May be requested in 6-10 wks (1) 1
OISE - Stacks (1) 1
Pontifical Inst. Mediaeval Studies - Library use only (1) 1
Robarts - Storage (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Rosell, Rafael, Dr and Carcereny, Enric, MD and Gervais, Radj, MD and Vergnenegre, Alain, Prof and Massuti, Bartomeu, MD and Felip, Enriqueta, MD and Palmero, Ramon, MD and Garcia-Gomez, Ramon, MD and Pallares, Cinta, MD and Sanchez, Jose Miguel, MD and Porta, Rut, MD and Cobo, Manuel, MD and Garrido, Pilar, MD and Longo, Flavia, MD and Moran, Teresa, MD and Insa, Amelia, MD and De Marinis, Filippo, MD and Corre, Romain, MD and Bover, Isabel, MD and Illiano, Alfonso, MD and Dansin, Eric, MD and de Castro, Javier, MD and Milella, Michele, MD and Reguart, Noemi, MD and Altavilla, Giuseppe, MD and Jimenez, Ulpiano, MD and Provencio, Mariano, MD and Moreno, Miguel Angel, MD and Terrasa, Josefa, MD and Muñoz-Langa, Jose, MD and Valdivia, Javier, MD and Isla, Dolores, MD and Domine, Manuel, MD and Molinier, Olivier, MD and Mazieres, Julien, Prof and Baize, Nathalie, MD and Garcia-Campelo, Rosario, MD and Robinet, Gilles, MD and Rodriguez-Abreu, Delvys, MD and Lopez-Vivanco, Guillermo, MD and Gebbia, Vittorio, MD and Ferrera-Delgado, Lioba, MD and Bombaron, Pierre, MD and Bernabe, Reyes, MD and Bearz, Alessandra, MD and Artal, Angel, MD and Cortesi, Enrico, MD and Rolfo, Christian, MD and Sanchez-Ronco, Maria, PhD and Drozdowskyj, Ana, PhD and Queralt, Cristina, PhD and de Aguirre, Itziar, PhD and Ramirez, Jose Luis, PhD and Sanchez, Jose Javier, Prof and Molina, Miguel Angel, PhD and Taron, Miquel, PhD and Paz-Ares, Luis, MD and Assoc Italiana Oncologia Toracica and Grp Francais Pneumocancerologie and Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia Toracica
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 3, pp. 239 - 246
Summary Background Erlotinib has been shown to improve progression-free survival compared with chemotherapy when given as first-line treatment for Asian... 
Hematology, Oncology and Palliative Medicine | IPASS | GEFITINIB | THERAPY | ONCOLOGY | SENSITIVITY | CARBOPLATIN/PACLITAXEL | TUMORS | Erlotinib Hydrochloride | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Prospective Studies | Exons | Lung Neoplasms - mortality | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Cisplatin - administration & dosage | Patient Selection | Time Factors | Female | Quinazolines - administration & dosage | Precision Medicine | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Europe | Kaplan-Meier Estimate | Proportional Hazards Models | Carboplatin - administration & dosage | Treatment Outcome | Chi-Square Distribution | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Protein Kinase Inhibitors - administration & dosage | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Quinazolines - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Deoxycytidine - analogs & derivatives | Antimitotic agents | Care and treatment | Chemotherapy | Erlotinib | Lung cancer | Product development | Agriculture | Lung cancer, Non-small cell | Antineoplastic agents | Standards | Cancer
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 12, pp. 1143 - 1150
Summary Background Sunitinib is a tyrosine kinase inhibitor with proven efficacy in renal-cell carcinoma, but some patients do not respond or need dose... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | VARIABILITY | INTERFERON-ALPHA | EFFICACY | ANGIOGENESIS | BIOMARKER | ONCOLOGY | GENOTYPE | VEGF | EXPRESSION | EXPOSURE | Predictive Value of Tests | Kidney Neoplasms - genetics | Prospective Studies | Humans | Middle Aged | Carcinoma, Renal Cell - genetics | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Patient Selection | Sunitinib | Cytochrome P-450 CYP3A - genetics | Time Factors | Antineoplastic Agents - adverse effects | Pyrroles - adverse effects | Female | Antineoplastic Agents - pharmacokinetics | Carcinoma, Renal Cell - drug therapy | Pyrroles - therapeutic use | Precision Medicine | Protein Kinase Inhibitors - pharmacokinetics | Genetic Predisposition to Disease | Risk Assessment | Carcinoma, Renal Cell - pathology | Gene Frequency | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Spain | Disease-Free Survival | Homozygote | Phenotype | Indoles - adverse effects | Protein Kinase Inhibitors - therapeutic use | Heterozygote | Indoles - therapeutic use | Kidney Neoplasms - pathology | Aged | Polymorphism, Single Nucleotide | Kidney Neoplasms - drug therapy | Vascular Endothelial Growth Factor Receptor-3 - genetics | Genetic markers | Carcinoma | Toxicity | Oncology | Single-nucleotide polymorphism | Gene polymorphism | Protein-tyrosine kinase | Survival | Interleukin 8 | Vascular endothelial growth factor receptors | Index Medicus
Journal Article
Journal of the Academy of Nutrition and Dietetics, ISSN 2212-2672, 2016, Volume 117, Issue 4, pp. 609 - 622.e1
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 91, Issue 1, pp. 165 - 171
Journal Article
Mayo Clinic Proceedings, ISSN 0025-6196, 2008, Volume 83, Issue 11, pp. 1213 - 1217
Journal Article
Surgery: Official Journal of the Society of University Surgeons, Central Surgical Association, and the American Association of Endocrine Surgeons, ISSN 0039-6060, 2012, Volume 151, Issue 1, pp. 84 - 93
Background The Nissen fundoplication procedure is the most widely used type of antireflux surgery. The results are not always as good as expected, and several... 
Surgery | SURGERY | NISSEN | GERD | REPAIR | GASTROESOPHAGEAL-REFLUX DISEASE | OPERATIONS | FUNDOPLICATION | GASTROPEXY | COMPLICATIONS | REINTERVENTION | HERNIA | Manometry | Gastroesophageal Reflux - surgery | Perioperative Period | Recurrence | Prospective Studies | Fundoplication - methods | Humans | Quality of Life | Female | Male | Treatment Outcome | Laparoscopy | Laparoscopic surgery
Journal Article
Foot and Ankle Surgery, ISSN 1268-7731, 2014, Volume 21, Issue 1, pp. e27 - e31
Highlights • We described a new variant of dorsal dislocation of the first metatarsophalangeal joint. • We classified it as a Jahss Type IIIA, a variant. • We... 
Orthopedics | First metatarsophalangeal joint dislocation | Sesamoid complex | Dislocation | GREAT TOE | ORTHOPEDICS | Radiography | Humans | Joint Dislocations - diagnostic imaging | Male | Aged | Metatarsophalangeal Joint - surgery | Joint Dislocations - surgery | Metatarsophalangeal Joint - injuries
Journal Article
Journal of Psychiatry and Neuroscience, ISSN 1180-4882, 2015, Volume 40, Issue 3, pp. 187 - 196
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 84, Issue 5, pp. 1151 - 1158
Purpose Management of locally advanced rectal cancer (RC) consists of neoadjuvant chemoradiotherapy (CRT) with fluoropyrimidines, followed by total mesorectal... 
Radiology | Hematology, Oncology and Palliative Medicine | TFF3 | Prognosis | Rectal cancer | Neoadjuvant treatment | Response prediction | CELLS | PREOPERATIVE CHEMORADIOTHERAPY | CHEMOTHERAPY | PREDICTION | ONCOLOGY | RESISTANCE | EXPRESSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Multivariate Analysis | Up-Regulation | Humans | Middle Aged | Peptides - genetics | Male | Neoplasm Proteins - metabolism | Protein Array Analysis - methods | Young Adult | Adenocarcinoma - metabolism | Peptides - metabolism | Rectal Neoplasms - genetics | Transfection - methods | Polymerase Chain Reaction | Aged, 80 and over | Trefoil Factor-3 | Adult | Female | Adenocarcinoma - genetics | Retrospective Studies | Neoplasm Proteins - genetics | Neoplasm Recurrence, Local | Gene Expression Profiling - methods | Rectal Neoplasms - therapy | Chemoradiotherapy, Adjuvant - methods | Disease-Free Survival | Drug Resistance, Neoplasm - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cell Line, Tumor | Aged | Rectal Neoplasms - metabolism | Care and treatment | Gene expression | Health aspects | Genes | Analysis | Cancer | SURGERY | APOPTOSIS | PATIENTS | URACILS | NEOPLASMS | RECTUM | BIOPSY | MULTIVARIATE ANALYSIS | FORECASTING | HEALTH HAZARDS | POLYMERASE CHAIN REACTION | IN VITRO | GENES | RADIOLOGY AND NUCLEAR MEDICINE | CELL CYCLE | SECRETION | COMBINED THERAPY | CONTROL | MUCOUS MEMBRANES
Journal Article
Journal Article
Surgical Neurology, ISSN 0090-3019, 2007, Volume 67, Issue 5, pp. 487 - 491
Journal Article